Global Beta-lactam and Beta-lactamase Inhibitors Market, By Route Of Administration (Oral, Intravenous, Others), By Disease (Urinary Tract Infection (excluding cUTI), Respiratory Infection, Skin Infection, Complicated Urinary Tract Infection (cUTI), Complicated Intra-Abdominal Infections (cIAI), Nosocomial Pneumonia, Blood Stream Infection, Other), By Drug Class (Penicillin, Cephalosporin, Carbapenem, Monobactam, Combination), and opportunities and forecast 2020-2027
  • DLR2369
  • 12 October, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global

* indicates mandatory fields